37. Fujino H, Yamada I, Shimada S, Yoneda M (2001) Simultaneous determination of taxol and its metabolites in microsomal samples by a simple thin-layer chromatography radioactivity assay–inhibitory effect of NK-104, a new inhibitor of HMG-CoA reductase. J Chromatogr B Biomed Sci Appl 757: 143–150. 38. Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95–105. 39. Mills GB, Moolenaar WH (2003) The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3: 582–591. 40. Chen M, Towers LN, O’Connor KL (2007) LPA2 (EDG4) mediates Rho- dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells. Am J Physiol Cell Physiol 292: C1927–1933. 41. Lanni JS, Jacks T (1998) Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 18: 1055–1064. 42. Blajeski AL, Kottke TJ, Kaufmann SH (2001) A multistep model for paclitaxel- induced apoptosis in human breast cancer cell lines. Exp Cell Res 270: 277–288. 43. Tao W, South VJ, Zhang Y, Davide JP, Farrell L, et al. (2005) Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer Cell 8: 49–59. 44. Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, et al. (2001) Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res 61: 6938–6944. 45. Lin S, Wang D, Iyer S, Ghaleb AM, Shim H, et al. (2009) The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. Gastroenterology 136: 1711–1720. 46. Lin FT, Lai YJ, Makarova N, Tigyi G, Lin WC (2007) The lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival. J Biol Chem 282: 37759–37769. 47. Okudaira S, Yukiura H, Aoki J (2010) Biological roles of lysophosphatidic acid signaling through its production by autotaxin. Biochimie 92: 698–706. 48. Montenarh M (2010) Cellular regulators of protein kinase CK2. Cell Tissue Res 342: 139–146. 49. Yamane K, Kinsella TJ (2005) Casein kinase 2 regulates both apoptosis and the cell cycle following DNA damage induced by 6-thioguanine. Clin Cancer Res 11: 2355–2363. Lysophosphatidate Reverses G2/M Arrest by Taxol 50. Martin A, Duffy PA, Liossis C, Go´mez-Mu n˜oz A, O’Brien L, et al. (1997) Increased concentrations of phosphatidate, diacylglycerol and ceramide in ras- and tyrosine kinase (fps)-transformed fibroblasts. Oncogene 14: 1571–1580. 51. Imai A, Furui T, Tamaya T, Mills GB (2000) A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells. J Clin Endocrinol Metab 85: 3370–3375. 52. Tanyi JL, Hasegawa Y, Lapushin R, Morris AJ, Wolf JK, et al. (2003) Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysopho- sphatidic acid in ovarian cancer. Clin Cancer Res 9: 3534–3545. 53. Tanyi JL, Morris AJ, Wolf JK, Fang X, Hasegawa Y, et al. (2003) The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer. Cancer Res 63: 1073–1082. 54. Pilquil C, Dewald J, Cherney A, Gorshkova I, Tigyi G, et al. (2006) Lipid phosphate phosphatase-1 regulates lysophosphatidate-induced fibroblast migra- tion by controlling phospholipase D2-dependent phosphatidate generation. J Biol Chem 281: 38418–38429. 55. Morris KE, Schang LM, Brindley DN (2006) Lipid phosphate phosphatase-2 activity regulates S-phase entry of the cell cycle in Rat2 fibroblasts. J Biol Chem 281: 9297–9306. 56. Brindley DN, Pilquil C (2009) Lipid phosphate phosphatases and signaling. J Lipid Res 50 Suppl: S225–230. 57. Terry NH, White RA (2006) Flow cytometry after bromodeoxyuridine labeling to measure S and G2+M phase durations plus doubling times in vitro and in vivo. Nat Protoc 1: 859–869. 58. Giannakakou P, Robey R, Fojo T, Blagosklonny MV (2001) Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 20: 3806–3813. 59. Kavallaris M, Tait AS, Walsh BJ, He L, Horwitz SB, et al. (2001) Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Cancer Res 61: 5803–5809. 60. Verrills NM, Flemming CL, Liu M, Ivery MT, Cobon GS, et al. (2003) Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactions. Chem Biol 10: 597–607. PLoS ONE | www.plosone.org 12 May 2011 | Volume 6 | Issue 5 | e20608